Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)

NCT01666119 is registered in ClinicalTrials.gov with BioDelivery Sciences International as lead sponsor.

NCT NCT01666119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)
Lead sponsor
BioDelivery Sciences International
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
January 31, 2013
Enrollment
249 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence